Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and...
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection
About this item
Full title
Author / Creator
Ali, Youssif Mohammed , Hayat, Azam , Saeed, Bayad Mawlood , Haleem, Kashif S. , Alshamrani, Saleh , Kenawy, Hany I. , Ferreira, Viviana P. , Saggu, Gurpanna , Buchberger, Anna , Lachmann, Peter J. , Sim, Robert B. , Goundis, Dimitrios , Andrew, Peter W. , Lyncha, Nicholas J. and Schwaeble, Wilhelm J.
Publisher
United States: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
Modern medicine has established three central antimicrobial therapeutic concepts: vaccination, antibiotics, and, recently, the use of active immunotherapy to enhance the immune response toward specific pathogens. The efficacy of vaccination and antibiotics is limited by the emergence of new pathogen strains and the increased incidence of antibiotic...
Alternative Titles
Full title
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1524396694
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1524396694
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.1401011111
